Managed Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alfacell Corp.
Data on the effectiveness of Onconase presented at conference
October 9th, 2005
Alfacell Corporation (ACEL) announced that Intae Lee, PhD, Department of Radiology, University of Pennsylvania, presented new data on the effectiveness of Onconase against non-small cell lung cancer (NSCLC) at the 33rd Annual Meeting of the International Society on Oxygen Transport to Tissue (ISOTT). Lee's presentation was entitled, "Possible Mechanisms of Improved Radiation Response by the Cytotoxic RNase, Onconase, on A549 Human Lung Cancer Xenografts of Nude Mice." "Our current studies illustrate the remarkable effect of Onconase as a single agent against NSCLC," stated Lee. "Specifically, Onconase, when combined with radiation therapy, was shown...
Source: Managed Care Law Weekly (2005-10-09)
|
